966-19754-25445
3 vaccinations
23 coded responses
40 check-ins
23 free-text entries
9 call cases
- Sex
- Female
- Age at first dose
- 46-50
- ZIP prefix
- 481 / MI
- Registered
- 2021-03-16
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-03-15
Dose 1 — Moderna
-
2021-03-16
Registered in v-safe
-
2021-03-16
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Site: Pain, Swelling, Itching · Fever · Chills, Headache, Fatigue or tiredness, Nausea, Abdominal pain, Rash, not including the immediate area around the injection site · Be unable to do your normal daily activitiesAdult check-in
-
2021-03-17
Health check-in — days 1–6 daily, dose 1Feeling: Poor · Site: Pain, Itching · Fever · Chills, Headache, Fatigue or tiredness, Nausea, Abdominal pain, Rash, not including the immediate area around the injection site · Be unable to do your normal daily activitiesAdult check-in
-
2021-03-18
Survey response — days 1–6 daily, dose 1MedDRA: Cold sweat — Feeling: Poor · Site: Pain · Fever · Chills, Headache, Joint pains, Fatigue or tiredness, Nausea, Vomiting, Abdominal pain · Be unable to do your normal daily activitiesFree text: Cold sweatsMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-03-19
Survey response — days 1–6 daily, dose 1MedDRA: Hyperhidrosis — Feeling: Poor · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea, Abdominal pain · Be unable to do your normal daily activitiesFree text: SweatingMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-03-20
Survey response — days 1–6 daily, dose 1MedDRA: Blue toe syndrome, Skin discolouration — Feeling: Poor · Chills, Headache, Joint pains, Fatigue or tiredness, Nausea, Abdominal pain · Be unable to do your normal daily activitiesFree text: Blueish/purple finger tios and toesMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-03-21
Survey response — days 1–6 daily, dose 1MedDRA: Cyanosis, Skin discolouration — Feeling: Fair · Headache, Joint pains, Fatigue or tiredness · Be unable to do your normal daily activitiesFree text: Blue/purple color to finger tips, back of hands, and toesMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-03-22
Health check-in — day 7, dose 1Feeling: Fair · Headache, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
- 2021-03-29
- 2021-04-05
-
2021-04-12
Dose 2 — Moderna
-
2021-04-12
Survey response — day 0, dose 2MedDRA: Chest discomfort, Swollen tongue, Throat irritation, Urticaria — Feeling: Poor · Site: Redness, ItchingFree text: Hives, throat itching, chest tightness, tongue slightly swollenMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-13
Survey response — days 1–6 daily, dose 2MedDRA: Skin discolouration — Feeling: Poor · Site: Pain, Swelling, Itching · Fever · Chills, Headache, Muscle or body aches, Fatigue or tiredness, Nausea, Rash, not including the immediate area around the injection site · Be unable to do your normal daily activitiesFree text: Bluish color to finger tipsMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-14
Survey response — days 1–6 daily, dose 2MedDRA: Cyanosis — Feeling: Poor · Site: Pain, Swelling, Itching · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to do your normal daily activitiesFree text: Bluish color to finger tipsMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-15
Survey response — days 1–6 daily, dose 2MedDRA: Cyanosis — Feeling: Poor · Site: Pain · Fever · Chills, Headache, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesFree text: Bluish color to finger tipsMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-16
Survey response — days 1–6 daily, dose 2MedDRA: Blue toe syndrome, Cyanosis — Feeling: Fair · Fever · Headache, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesFree text: Bluish tint to finger tiosMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-17
Survey response — days 1–6 daily, dose 2MedDRA: Cyanosis — Feeling: Fair · Fatigue or tiredness · Be unable to do your normal daily activitiesFree text: Blue color to finger tipsMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-18
Survey response — days 1–6 daily, dose 2MedDRA: Dizziness, Skin discolouration — Feeling: Fair · Fatigue or tiredness · Be unable to do your normal daily activitiesFree text: Blue color to fingertuos, dizzinessMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-19
Survey response — day 7, dose 2MedDRA: Skin discolouration — Feeling: Fair · Fatigue or tiredness · Be unable to do your normal daily activitiesFree text: Blue color to fingertipsMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-04-26
- 2021-05-03
- 2021-05-10
-
2021-05-17
Survey response — day 35, dose 2MedDRA: Oral herpes — Feeling: Good · Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: Non stop cold soresMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-05-17
Report sent to call center — day 35, dose 2Get care from a doctor or other healthcare professional1 call case(s)
-
2021-05-24
Survey response — day 42, dose 2MedDRA: Oral herpes — Feeling: Good · Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: Frequent cold soresMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-05-24
Report sent to call center — day 42, dose 2Get care from a doctor or other healthcare professional1 call case(s)
-
2021-07-12
Survey response — 3 months, dose 2MedDRA: Oral herpes — Feeling: GoodFree text: Persistent and reoccurring cold soreMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-10-11
-
2021-12-22
Dose 3 — Pfizer-BioNTech
-
2021-12-22
Survey response — day 0, dose 3MedDRA: Palpitations — Feeling: Fair · Site: Pain, Redness, Itching · Headache, Nausea, Rash, not including the immediate area around the injection siteFree text: Heart palpitationsMedDRA releases: 2024-11 · check-in free text available
-
2021-12-23
Survey response — days 1–6 daily, dose 3MedDRA: Palpitations — Feeling: Poor · Site: Pain, Itching · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea, Rash, not including the immediate area around the injection site · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: Heart palpitationsMedDRA releases: 2024-11 · check-in free text available
-
2021-12-23
Report sent to call center — days 1–6 daily, dose 3Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prTelehealth, virtual health, or email health consultation · 1 call case(s)
-
2021-12-24
Survey response — days 1–6 daily, dose 3MedDRA: Palpitations — Feeling: Poor · Site: Pain · Fever · Chills, Muscle or body aches, Fatigue or tiredness, Abdominal pain · Be unable to work or attend school, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: Heart palpitationsMedDRA releases: 2024-11 · check-in free text available
-
2021-12-24
Report sent to call center — days 1–6 daily, dose 3Be unable to work or attend school · Get care from a doctor or other healthcare professionalTelehealth, virtual health, or email health consultation · 1 call case(s)
-
2021-12-25
Health check-in — days 1–6 daily, dose 3Feeling: Poor · Fever · Chills, Headache, Muscle or body aches · Be unable to work or attend schoolAdult check-in
-
2021-12-26
Survey response — days 1–6 daily, dose 3MedDRA: Angina pectoris, Chest pain, Cough, Oropharyngeal pain — Feeling: Poor · Fever · Chills, Headache, Muscle or body aches, Fatigue or tiredness · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Cough, chest pain, sore throat, heart painMedDRA releases: 2024-11 · check-in free text available
-
2021-12-26
Report sent to call center — days 1–6 daily, dose 3Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prOutpatient clinic or urgent care clinic visit · 1 call case(s)
-
2021-12-27
Survey response — days 1–6 daily, dose 3MedDRA: Chest discomfort, Cough — Feeling: Poor · Fever · Chills, Muscle or body aches, Fatigue or tiredness · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: Cough, chest tightnessMedDRA releases: 2024-11 · check-in free text available
-
2021-12-27
Report sent to call center — days 1–6 daily, dose 3Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prTelehealth, virtual health, or email health consultation · 1 call case(s)
- 2021-12-27
-
2021-12-28
Survey response — days 1–6 daily, dose 3MedDRA: SARS-CoV-2 test positive — Feeling: Poor · Fever · Chills, Headache, Muscle or body aches, Fatigue or tiredness, Abdominal pain · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: Tested positve for covidMedDRA releases: 2024-11 · check-in free text available
-
2021-12-28
Report sent to call center — days 1–6 daily, dose 3Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prTelehealth, virtual health, or email health consultation · 1 call case(s)
-
2021-12-29
Survey response — day 7, dose 3MedDRA: COVID-19 — Feeling: Poor · Fever · Chills, Headache, Fatigue or tiredness · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: Covid positiveMedDRA releases: 2024-11 · check-in free text available
-
2021-12-29
Report sent to call center — day 7, dose 3Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prTelehealth, virtual health, or email health consultation · 1 call case(s)
- 2021-12-30
- 2022-01-05
-
2022-01-12
Survey response — day 21, dose 3MedDRA: COVID-19, Pneumonia, Pyrexia, Sinusitis — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: Secondary Covid related sinus infection, pneumonia, and recurrent fevers.MedDRA releases: 2024-11 · check-in free text available
-
2022-01-12
Report sent to call center — day 21, dose 3Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prTelehealth, virtual health, or email health consultation · 1 call case(s)
- 2022-01-13
- 2022-01-18
- 2022-01-21
- 2022-01-26
- 2022-02-04
- 2022-03-23
- 2022-06-22
- 2022-12-22
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-15 | Moderna | |
| 2 | 2021-04-12 | Moderna | |
| 3 | 2021-12-22 | Pfizer-BioNTech | No |
Call center
9 call center cases
9 unsuccessful
Free text
Release 5 — days 1–6 daily, dose 1
Systemic reaction (other): Cold sweats
Release 6 — days 1–6 daily, dose 1
Systemic reaction (other): Sweating
Systemic reaction (other): Blueish/purple finger tios and toes
Systemic reaction (other): Blue/purple color to finger tips, back of hands, and toes
Release 7 — day 0, dose 2
Systemic reaction (other): Hives, throat itching, chest tightness, tongue slightly swollen
Release 7 — days 1–6 daily, dose 2
Systemic reaction (other): Bluish color to finger tips
Systemic reaction (other): Bluish color to finger tips
Systemic reaction (other): Bluish color to finger tips
Systemic reaction (other): Bluish tint to finger tios
Systemic reaction (other): Blue color to finger tips
Systemic reaction (other): Blue color to fingertuos, dizziness
Release 7 — day 7, dose 2
Systemic reaction (other): Blue color to fingertips
Release 8 — day 35, dose 2
Symptoms: Non stop cold sores
Release 8 — day 42, dose 2
Symptoms: Frequent cold sores
Release 9 — 3 months, dose 2
Symptoms: Persistent and reoccurring cold sore
Release 10 — day 0, dose 3
Systemic reaction (other): Heart palpitations
Release 10 — days 1–6 daily, dose 3
Systemic reaction (other): Heart palpitations
Systemic reaction (other): Heart palpitations
Systemic reaction (other): Cough, chest pain, sore throat, heart pain
Systemic reaction (other): Cough, chest tightness
Systemic reaction (other): Tested positve for covid
Release 10 — day 7, dose 3
Systemic reaction (other): Covid positive
Release 10 — day 21, dose 3
Symptoms: Secondary Covid related sinus infection, pneumonia, and recurrent fevers.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | COVID-19 | · | · | ✓ |
| SD | Oral herpes | ✓ | ✓ | ✓ |
| SD | Pneumonia | · | · | ✓ |
| SD | Pyrexia | · | · | ✓ |
| SD | Sinusitis | · | · | ✓ |
| SRO | Angina pectoris | · | · | ✓ |
| SRO | Blue toe syndrome | ✓ | ✓ | ✓ |
| SRO | Chest discomfort | ✓ | ✓ | ✓ |
| SRO | Chest pain | · | · | ✓ |
| SRO | Cold sweat | ✓ | ✓ | ✓ |
| SRO | Cough | · | · | ✓ |
| SRO | COVID-19 | · | · | ✓ |
| SRO | Cyanosis | ✓ | ✓ | ✓ |
| SRO | Dizziness | ✓ | ✓ | ✓ |
| SRO | Hyperhidrosis | ✓ | ✓ | ✓ |
| SRO | Oropharyngeal pain | · | · | ✓ |
| SRO | Palpitations | · | · | ✓ |
| SRO | SARS-CoV-2 test positive | · | · | ✓ |
| SRO | Skin discolouration | ✓ | ✓ | ✓ |
| SRO | Swollen tongue | ✓ | ✓ | ✓ |
| SRO | Throat irritation | ✓ | ✓ | ✓ |
| SRO | Urticaria | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release